Put Options

13 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $180,614 - $211,888
1,900 New
1,900 $208,000
Q2 2020

Aug 14, 2020

SELL
$76.57 - $98.0 $3.02 Million - $3.86 Million
-39,400 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$62.82 - $91.86 $21.6 Million - $31.5 Million
-343,300 Reduced 89.7%
39,400 $3.11 Million
Q4 2019

Feb 13, 2020

SELL
$78.51 - $87.4 $12.8 Million - $14.2 Million
-163,000 Reduced 29.87%
382,700 $33.2 Million
Q3 2019

Nov 13, 2019

BUY
$81.84 - $88.74 $27.2 Million - $29.4 Million
331,800 Added 155.12%
545,700 $45.7 Million
Q2 2019

Aug 13, 2019

BUY
$72.88 - $85.0 $9.41 Million - $11 Million
129,100 Added 152.24%
213,900 $18 Million
Q1 2019

May 08, 2019

SELL
$66.22 - $80.06 $24 Million - $29 Million
-361,800 Reduced 81.01%
84,800 $6.78 Million
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $16.7 Million - $18.9 Million
254,800 Added 132.85%
446,600 $32.3 Million
Q3 2018

Nov 13, 2018

BUY
$60.81 - $73.36 $3.2 Million - $3.87 Million
52,700 Added 37.89%
191,800 $14.1 Million
Q2 2018

Aug 13, 2018

SELL
$57.57 - $63.54 $1.42 Million - $1.57 Million
-24,700 Reduced 15.08%
139,100 $8.48 Million
Q1 2018

May 14, 2018

SELL
$56.27 - $63.62 $1.67 Million - $1.89 Million
-29,700 Reduced 15.35%
163,800 $9.82 Million
Q4 2017

Feb 13, 2018

BUY
$53.68 - $57.47 $6.08 Million - $6.51 Million
113,300 Added 141.27%
193,500 $11 Million
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $3.85 Million - $4.3 Million
80,200
80,200 $4.28 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.